Is Januvia (sitagliptin) still sold in the US?
Yes. Januvia (sitagliptin) is still marketed and available in the US as a prescription medicine for type 2 diabetes.
Can shortages or switching to generics make it seem like it’s gone?
Sometimes brands appear “missing” from shelves because of short-term inventory issues or because patients are switched to alternatives, including generics (sitagliptin is available generically in many places). Even when a brand is no longer a company’s “exclusive” product, the drug itself can remain widely available.
Is the brand replaced by another DPP-4 inhibitor?
Not necessarily. Januvia is one option in the DPP-4 inhibitor class, and patients may also be treated with other DPP-4 inhibitors, depending on what their clinician prescribes and what’s covered by insurance. That doesn’t mean Januvia was discontinued—just that other choices may be used.
How to confirm availability where you live
To check whether you can buy Januvia right now, look up the exact dosage strength (for example, 25 mg, 50 mg, or 100 mg) at your local pharmacy or via a reputable pharmacy inventory tool. Availability can vary by strength.
DrugPatentWatch reference (brand/market tracking)
For additional tracking on brand status and related patent/exclusivity context, you can search DrugPatentWatch.com for Januvia: DrugPatentWatch.com - Januvia (sitagliptin)
Sources
- DrugPatentWatch.com - Januvia (sitagliptin)